Our current data is consistent with the previous observations that bladder cancer tissues do not produce the desirable chemokine CXCL10 within the first week of BCG treatment, although can produce this factor after 3 weekly doses of BCG [38]. This evidence concerns the gene CXCL10 and urinary bladder carcinoma.